SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-24-163207
Filing Date
2024-06-18
Accepted
2024-06-18 11:51:59
Documents
13
Period of Report
2024-06-14
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d834577d8ka.htm   iXBRL 8-K/A 32630
  Complete submission text file 0001193125-24-163207.txt   162429

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA avro-20240614.xsd EX-101.SCH 2850
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE avro-20240614_lab.xml EX-101.LAB 18701
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avro-20240614_pre.xml EX-101.PRE 11695
16 EXTRACTED XBRL INSTANCE DOCUMENT d834577d8ka_htm.xml XML 4509
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617.914.8420
AVROBIO, Inc. (Filer) CIK: 0001681087 (see all company filings)

IRS No.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38537 | Film No.: 241050685
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)